MILPITAS, CA. November 21, 2022 – MagArray, Inc., the leading developer of advanced medical diagnostics using magnetic nanosensor technology, announced that CHEST, the peer-reviewed journal of The American College of Chest Physicians,…
MILPITAS, CA. March 5, 2019 – MagArray, the leading developer of advanced medical diagnostics using magnetic nanosensor technology, announced the prestigious selection of our late-breaking abstract for presentation at ATS…
MILPITAS, CA. September 7, 2018 – MagArray, the leading developer of advanced medical diagnostics using magnetic nanosensor technology, announced the prestigious selection of our late-breaking abstract for oral presentation at…
MILPITAS, CA. August 1, 2018 – On this World Lung Cancer Day, MagArray, the leading developer of advanced medical diagnostics using magnetic nanosensor technology, announced the US market launch of…
Tokyo, Japan, September 21, 2017—Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced today that it would enter the diagnostic testing service business by accepting a private placement of new shares…
IMRA America, Inc. (IMRA) and MagArray, Inc. have announced the establishment of a corporate partnership to further the development of MagArray’s novel magneto-nanoparticle immunoassay technology that is based on research outcome from Stanford University.